PFM Health Sciences, LP
An institutional investment manager in SAN FRANCISCO, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1442756.
- Reported value$1.17bn
- Positions98
Holdings: 98 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Ascendis Pharma A/S | ORD SHS | K08588103 | 62.2 | 5.3% | 233,171 | New+233,171 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 53.8 | 4.6% | 219,596 | Reduced−44,708 | |
| ELI Lilly & CoLLY | COM | 532457108 | 47.1 | 4.0% | 39,258 | Reduced−26,504 | |
| Jazz Pharmaceuticals plc | SHS USD | G50871105 | 38.7 | 3.3% | 160,768 | Reduced−17,376 | |
| Humana IncHUM | COM | 444859102 | 37.5 | 3.2% | 94,375 | New+94,375 | |
| Unitedhealth Group IncUNH | COM | 91324P102 | 36.7 | 3.1% | 88,276 | Added+30,238 | |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 36.0 | 3.1% | 213,407 | Reduced−2,271 | |
| Inhibrx Biosciences IncINBX | COM | 45720N103 | 29.2 | 2.5% | 308,385 | Added+2,954 | |
| United Therapeutics Corp DelUTHR | COM | 91307C102 | 27.1 | 2.3% | 49,991 | Added+10,186 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 26.8 | 2.3% | 143,222 | Added+2,452 | |
| Icon Pub Ltd Co | SHS | G4705A100 | 23.7 | 2.0% | 136,482 | Added+78,982 | |
| Tenet Healthcare CorpTHC | COM NEW | 88033G407 | 23.7 | 2.0% | 126,572 | Reduced−271,995 | |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 22.7 | 1.9% | 250,453 | Reduced−4,057 | |
| Waters CorpWAT | COM | 941848103 | 22.4 | 1.9% | 59,825 | Added+20,062 | |
| Penumbra IncPEN | COM | 70975L107 | 19.0 | 1.6% | 60,221 | Reduced−79,558 | |
| Bridgebio Pharma IncBBIO | COM | 10806X102 | 18.9 | 1.6% | 253,358 | Reduced−4,389 | |
| Stryker CorporationSYK | COM | 863667101 | 17.8 | 1.5% | 56,637 | Added+34,680 | |
| Mettler Toledo InternationalMTD | COM | 592688105 | 17.0 | 1.5% | 13,344 | New+13,344 | |
| Indivior Pharmaceuticals IncINDV | COM | 45579U109 | 16.5 | 1.4% | 401,208 | Reduced−173,458 | |
| Merck & Co IncMRK | COM | 58933Y105 | 16.3 | 1.4% | 127,118 | New+127,118 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 16.3 | 1.4% | 191,686 | New+191,686 | |
| Lantheus Holdings IncLNTH | COM | 516544103 | 16.2 | 1.4% | 146,403 | New+146,403 | |
| Centene Corp DelCNC | COM | 15135B101 | 16.0 | 1.4% | 248,867 | Reduced−14,619 | |
| Cooper Cos IncCOO | COM | 216648501 | 15.8 | 1.4% | 220,890 | Added+51,061 | |
| Madrigal Pharmaceuticals IncMDGL | COM | 558868105 | 15.7 | 1.4% | 29,313 | Reduced−4,833 | |
| Acadia Healthcare Company inACHC | COM | 00404A109 | 15.5 | 1.3% | 524,934 | Reduced−57,811 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 15.1 | 1.3% | 158,825 | Reduced−15,227 | |
| Oscar Health IncOSCR | CL A | 687793109 | 14.8 | 1.3% | 519,016 | Added+19,179 | |
| Thermo Fisher Scientific IncTMO | COM | 883556102 | 14.3 | 1.2% | 28,496 | Added+13,664 | |
| CVS Health CorpCVS | COM | 126650100 | 14.2 | 1.2% | 137,457 | New+137,457 | |
| Merit Med Sys IncMMSI | COM | 589889104 | 13.7 | 1.2% | 197,038 | Added+34,569 | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 12.9 | 1.1% | 38,575 | Added+3,137 | |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 12.8 | 1.1% | 342,751 | Added+17,794 | |
| Novo-Nordisk a SNVO | ADR | 670100205 | 12.7 | 1.1% | 265,016 | Added+67,835 | |
| Integer Holdings CorpITGR | COM | 45826H109 | 11.8 | 1.0% | 126,669 | Reduced−8,412 | |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 11.8 | 1.0% | 121,222 | Reduced−50,915 | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 11.7 | 1.0% | 249,020 | Added+43,703 | |
| Gilead Sciences IncGILD | COM | 375558103 | 11.5 | 1.0% | 90,858 | New+90,858 | |
| Rhythm Pharmaceuticals IncRYTM | COM | 76243J105 | 11.3 | 1.0% | 101,550 | Reduced−35,071 | |
| Schein Henry IncHSIC | COM | 806407102 | 11.2 | 1.0% | 134,423 | Reduced−18,691 | |
| Arrowhead Pharmaceuticals inARWR | COM | 04280A100 | 10.7 | 0.9% | 131,667 | Added+67,388 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 10.2 | 0.9% | 326,047 | Reduced−80,198 | |
| Teleflex IncorporatedTFX | COM | 879369106 | 10.1 | 0.9% | 79,708 | New+79,708 | |
| Viking Therapeutics IncVKTX | COM | 92686J106 | 10.0 | 0.9% | 255,330 | Reduced−7,776 | |
| Brightspring Health SVCS IncBTSG | COM | 10950A106 | 9.9 | 0.8% | 141,914 | Reduced−45,421 | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 9.6 | 0.8% | 224,289 | Added+49,422 | |
| Roivant Sciences Ltd | SHS | G76279101 | 9.5 | 0.8% | 268,008 | Added+60,562 | |
| CG Oncology IncCGON | COM | 156944100 | 9.1 | 0.8% | 128,286 | Reduced−37,639 | |
| Amneal Pharmaceuticals IncAMRX | COM STK CL A | 03168L105 | 8.3 | 0.7% | 480,715 | Reduced−449,381 | |
| Eupraxia Pharmaceuticals IncEPRX | COM | 29842P105 | 8.0 | 0.7% | 1,210,661 | Added+669,790 | |
| Cencora IncCOR | COM | 03073E105 | 8.0 | 0.7% | 28,100 | Call | New+28,100 |
| Irhythm Holdings IncIRTC | COM | 450056106 | 7.8 | 0.7% | 65,196 | New+65,196 | |
| Kodiak Sciences IncKOD | COM | 50015M109 | 7.5 | 0.6% | 193,315 | Added+78,596 | |
| Abbott LaboratoriesABT | COM | 002824100 | 7.5 | 0.6% | 82,230 | Reduced−58,202 | |
| West Pharmaceutical SVSC IncWST | COM | 955306105 | 7.4 | 0.6% | 20,733 | New+20,733 | |
| Takeda Pharmaceutical Co LtdTAK | SPONSORED ADS | 874060205 | 7.1 | 0.6% | 444,173 | New+444,173 | |
| Hinge Health IncHNGE | CL A | 433313103 | 6.9 | 0.6% | 82,860 | New+82,860 | |
| Arcutis Biotherapeutics IncARQT | COM | 03969K108 | 6.3 | 0.5% | 242,069 | New+242,069 | |
| Integra Lifesciences Holdings CIART | COM NEW | 457985208 | 6.3 | 0.5% | 348,746 | New+348,746 | |
| Illumina IncILMN | COM | 452327109 | 6.2 | 0.5% | 35,040 | Added+6,171 | |
| Meiragtx Holdings plc | COM | G59665102 | 6.2 | 0.5% | 455,286 | New+455,286 | |
| Oculis Holding AG | ORDINARY SHARES | H5870P102 | 6.0 | 0.5% | 436,042 | New+436,042 | |
| Natera IncNTRA | COM | 632307104 | 6.0 | 0.5% | 22,077 | Reduced−37,927 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 5.8 | 0.5% | 43,264 | Added+16,600 | |
| Centene Corp DelCNC | COM | 15135B101 | 5.7 | 0.5% | 88,200 | Put | New+88,200 |
| Guardant Health IncGH | COM | 40131M109 | 5.5 | 0.5% | 36,701 | New+36,701 | |
| Celcuity IncCELC | COM | 15102K100 | 5.5 | 0.5% | 52,155 | New+52,155 | |
| Belite Bio IncBLTE | SPONSORED ADS | 07782B104 | 5.4 | 0.5% | 34,803 | Reduced−24,629 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 4.9 | 0.4% | 91,550 | Reduced−34,833 | |
| Arcus Biosciences IncRCUS | COM | 03969F109 | 4.7 | 0.4% | 152,129 | New+152,129 | |
| Charles Riv Labs International IncCRL | COM | 159864107 | 4.3 | 0.4% | 18,747 | New+18,747 | |
| Elanco Animal Health IncELAN | COM | 28414H103 | 4.2 | 0.4% | 172,489 | New+172,489 | |
| Argenx SEARGX | SPONSORED ADR | 04016X101 | 4.2 | 0.4% | 4,482 | Reduced−53 | |
| Bio Rad Labs IncBIO | CL A | 090572207 | 4.1 | 0.4% | 13,995 | New+13,995 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 4.1 | 0.4% | 46,217 | New+46,217 | |
| MBX Biosciences IncMBX | COM | 55287L101 | 3.9 | 0.3% | 70,971 | Reduced−923 | |
| Mirum Pharmaceuticals IncMIRM | COM | 604749101 | 3.7 | 0.3% | 31,536 | New+31,536 | |
| Cullinan Therapeutics IncCGEM | COM | 230031106 | 3.5 | 0.3% | 192,442 | Reduced−34,964 | |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 3.5 | 0.3% | 247,589 | Reduced−1,119,510 | |
| HCA Healthcare IncHCA | COM | 40412C101 | 3.2 | 0.3% | 8,295 | Reduced−5,056 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 2.9 | 0.3% | 122,221 | Reduced−1,610 | |
| Denali Therapeutics IncDNLI | COM | 24823R105 | 2.6 | 0.2% | 100,966 | New+100,966 | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 2.6 | 0.2% | 118,422 | Reduced−126,599 | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 2.6 | 0.2% | 143,700 | Reduced−1,575 | |
| Tarsus Pharmaceuticals IncTARS | COM | 87650L103 | 2.6 | 0.2% | 40,579 | Reduced−39,647 | |
| Outset Med IncOM | COM NEW | 690145206 | 2.5 | 0.2% | 582,122 | Reduced−12,508 | |
| Omada Health IncOMDA | COM | 68170A108 | 2.5 | 0.2% | 114,442 | New+114,442 | |
| Erasca IncERAS | COM | 29479A108 | 2.5 | 0.2% | 134,088 | New+134,088 | |
| Cencora IncCOR | COM | 03073E105 | 2.1 | 0.2% | 7,385 | New+7,385 | |
| Biocryst Pharmaceuticals IncBCRX | COM | 09058V103 | 2.1 | 0.2% | 207,357 | New+207,357 | |
| Omnicell ComOMCL | COM | 68213N109 | 2.0 | 0.2% | 49,040 | New+49,040 | |
| CVRX IncCVRX | COM | 126638105 | 1.9 | 0.2% | 369,572 | New+369,572 | |
| Hims & Hers Health IncHIMS | COM CL A | 433000106 | 1.7 | 0.1% | 49,454 | New+49,454 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 1.7 | 0.1% | 62,418 | Reduced−80,259 | |
| Tectonic Therapeutic IncTECX | COM | 878972108 | 1.6 | 0.1% | 45,631 | Reduced−498 | |
| Uniqure NV | SHS | N90064101 | 1.2 | 0.1% | 26,396 | Reduced−16,239 | |
| Rezolute IncRZLT | COM NEW | 76200L309 | 0.7 | <0.1% | 127,289 | Reduced−1,437 | |
| Caribou Biosciences IncCRBU | COM | 142038108 | 0.6 | <0.1% | 354,687 | Reduced−603,100 |
Sold out: 20 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Alignment Healthcare IncALHC | COM | 01625V104 | 0.0 | 0.0% | 0 | Sold out−359,826 | |
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 0.0 | 0.0% | 0 | Call | Sold out−22,400 |
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 0.0 | 0.0% | 0 | Sold out−152,034 | |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | 0.0 | 0.0% | $0 principal | Sold out−11,505,000 | |
| Billiontoone IncBLLN | CL A | 090168105 | 0.0 | 0.0% | 0 | Sold out−88,069 | |
| Cardinal Health IncCAH | COM | 14149Y108 | 0.0 | 0.0% | 0 | Sold out−31,941 | |
| Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 0.0 | 0.0% | 0 | Sold out−528,224 | |
| Dexcom IncDXCM | COM | 252131107 | 0.0 | 0.0% | 0 | Sold out−149,734 | |
| Glaukos CorpGKOS | COM | 377322102 | 0.0 | 0.0% | 0 | Sold out−215,685 | |
| Globus Med IncGMED | CL A | 379577208 | 0.0 | 0.0% | 0 | Sold out−16,923 | |
| HCA Healthcare IncHCA | COM | 40412C101 | 0.0 | 0.0% | 0 | Put | Sold out−4,600 |
| Medline IncMDLN | COM CL A | 58507V107 | 0.0 | 0.0% | 0 | Sold out−86,777 | |
| Neogenomics IncNEO | COM NEW | 64049M209 | 0.0 | 0.0% | 0 | Sold out−1,784,552 | |
| Personalis IncPSNL | COM | 71535D106 | 0.0 | 0.0% | 0 | Sold out−870,097 | |
| Select Sector SPDR TR | STATE STREET HEA | 81369Y209 | 0.0 | 0.0% | 0 | Call | Sold out−238,900 |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Sold out−248,180 | |
| SPDR Series Trust | STATE STREET SPD | 78464A870 | 0.0 | 0.0% | 0 | Put | Sold out−455,300 |
| Terns Pharmaceuticals Inc | COM | 880881107 | 0.0 | 0.0% | 0 | Sold out−172,962 | |
| United Therapeutics Corp DelUTHR | COM | 91307C102 | 0.0 | 0.0% | 0 | Put | Sold out−45,900 |
| United Therapeutics Corp DelUTHR | COM | 91307C102 | 0.0 | 0.0% | 0 | Call | Sold out−31,700 |
Source: SEC EDGAR, Form 13F-HR, accession 0001442756-26-000006 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.